Golimumab rejected by NICE for psoriatic arthritis

Golimumab has not been recommended by NICE for use in treating psoriatic arthritis, under draft guidance issued by the institute.

The drug is licensed for the treatment of active and progressive arthritis in adults unresponsive to other therapy.

NICE has made the recommendation because research indicates that golimumab is not more cost-effective than other available options.

A spokesman said: 'NICE currently recommends adalimumab, etanercept and infliximab for the treatment of psoriatic arthritis in people who have peripheral arthritis. The cost-effectiveness analyses found that golimumab was not the most cost effective of the available options currently recommended by NICE.'

A secondary reason for the guidance was uncertainty about possible harmful side-effects of taking the drug, as a long-term follow up on adverse outcomes is ongoing.

The spokesman added: 'Based on the available evidence, golimumab was expected to be more costly than estimated in the economic model and less cost effective than etanercept, and so could not be considered a good use of NHS resources.'

The draft guidance is currently open to consultation.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Consultants in London on strike earlier this year

Consultants to vote on new pay deal to end strikes

Consultants will vote on a government pay offer that would increase salaries by up...

BMA England GP committee chair Dr Katie Bramall-Stainer (Photo: Sarah Turton/BMA)

GPs' willingness to take collective action will underpin contract talks

GPs' willingness to take part in 'once in a generation' collective action will underpin...

GP consultation

GPs out of work 'because practices can’t afford to hire them', warns GP leader

Growing numbers of GPs are struggling to find work - with some considering moving...

computer and stethoscope

Petition demanding SCA exam refund collects almost 2,000 signatures

Almost 2,000 people have signed a petition demanding refunds for doctors whose GP...

Dr Katie Bramall-Stainer, chair of the BMA's GP committee in England

Dr Katie Bramall-Stainer: 'The GMS contract is not broken - it has been broken'

BMA England GP committee chair Dr Katie Bramall-Stainer received a standing ovation...

LMC conference sign

LMCs demand formal ballot on outcome of GP contract talks

LMCs have demanded a formal ballot on the outcome of talks over next year's GP contract,...